| Ursodeoxycholic acid | Approved Investigational | ATF4 | 468 |
downregulated | Ursodeoxycholic Acid results in decreased expression of ATF4 mRNA | 22q13.1 | |
| Ursodeoxycholic acid | Approved Investigational | BLVRA | 644 |
upregulated | Ursodeoxycholic Acid results in increased expression of BLVRA mRNA | 7p13 | |
| Ursodeoxycholic acid | Approved Investigational | CCL2 | 6347 |
upregulated | Ursodeoxycholic Acid results in increased expression of CCL2 mRNA | 17q12 | |
| Ursodeoxycholic acid | Approved Investigational | CXCL1 | 2919 |
upregulated | Ursodeoxycholic Acid results in increased expression of CXCL1 mRNA | 4q13.3 | |
| Ursodeoxycholic acid | Approved Investigational | CYP3A4 | 1576 |
upregulated | Ursodeoxycholic Acid results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Ursodeoxycholic acid | Approved Investigational | CYP7A1 | 1581 |
downregulated | Ursodeoxycholic Acid results in decreased expression of CYP7A1 mRNA | 8q12.1 | |
| Ursodeoxycholic acid | Approved Investigational | DNAJC3 | 5611 |
downregulated | Ursodeoxycholic Acid results in decreased expression of DNAJC3 mRNA | 13q32.1 | |
| Ursodeoxycholic acid | Approved Investigational | EDN1 | 1906 |
downregulated | Ursodeoxycholic Acid results in decreased expression of EDN1 mRNA | 6p24.1 | |
| Ursodeoxycholic acid | Approved Investigational | FABP4 | 2167 |
downregulated | Ursodeoxycholic Acid results in decreased expression of FABP4 mRNA | 8q21.13 | |
| Ursodeoxycholic acid | Approved Investigational | FABP6 | 2172 |
upregulated | Ursodeoxycholic Acid results in increased expression of FABP6 mRNA | 5q33.3 | |
| Ursodeoxycholic acid | Approved Investigational | FASN | 2194 |
downregulated | Ursodeoxycholic Acid results in decreased expression of FASN mRNA | 17q25.3 | |
| Ursodeoxycholic acid | Approved Investigational | FGF19 | 9965 |
upregulated | Ursodeoxycholic Acid results in increased expression of FGF19 mRNA | 11q13.3 | |
| Ursodeoxycholic acid | Approved Investigational | GCLC | 2729 |
upregulated | Ursodeoxycholic Acid results in increased expression of GCLC mRNA | 6p12.1 | |
| Ursodeoxycholic acid | Approved Investigational | GCLM | 2730 |
upregulated | Ursodeoxycholic Acid results in increased expression of GCLM mRNA | 1p22.1 | |
| Ursodeoxycholic acid | Approved Investigational | GPBAR1 | 151306 |
downregulated | Ursodeoxycholic Acid results in decreased expression of GPBAR1 mRNA | 2q35 | |
| Ursodeoxycholic acid | Approved Investigational | GSS | 2937 |
upregulated | Ursodeoxycholic Acid results in increased expression of GSS mRNA | 20q11.22 | |
| Ursodeoxycholic acid | Approved Investigational | HLA-DRA | 3122 |
upregulated | Ursodeoxycholic Acid results in increased expression of HLA-DRA mRNA | 6p21.32 | |
| Ursodeoxycholic acid | Approved Investigational | HSPA5 | 3309 |
downregulated | Ursodeoxycholic Acid results in decreased expression of HSPA5 mRNA | 9q33.3 | |
| Ursodeoxycholic acid | Approved Investigational | MIR21 | 406991 |
upregulated | Ursodeoxycholic Acid results in increased expression of MIR21 mRNA | 17q23.1 | |
| Ursodeoxycholic acid | Approved Investigational | NR0B2 | 8431 |
upregulated | Ursodeoxycholic Acid results in increased expression of NR0B2 mRNA | 1p36.11 | |
| Ursodeoxycholic acid | Approved Investigational | NR1H4 | 9971 |
downregulated | Ursodeoxycholic Acid results in decreased expression of NR1H4 mRNA | 12q23.1 | |
| Ursodeoxycholic acid | Approved Investigational | NR1H4 | 9971 |
upregulated | Ursodeoxycholic Acid results in increased expression of NR1H4 mRNA | 12q23.1 | |
| Ursodeoxycholic acid | Approved Investigational | NR1I2 | 8856 |
upregulated | Ursodeoxycholic Acid results in increased expression of NR1I2 mRNA | 3q13.33 | |
| Ursodeoxycholic acid | Approved Investigational | PPARG | 5468 |
downregulated | Ursodeoxycholic Acid results in decreased expression of PPARG mRNA | 3p25.2 | |
| Ursodeoxycholic acid | Approved Investigational | SCD | 6319 |
downregulated | Ursodeoxycholic Acid results in decreased expression of SCD mRNA | 10q24.31 | |